Minisymposium der SCS, SCS / Division of Medicinal Chemistry

A bi-annual minisymposium organized by the DMCCB of the Swiss Chemical Society on a cutting edge topic. This years topic is «Epigenetic Targets: New opportunities for medicinal chemistry»

Start Date 07.06.2012 - 14:00
Event End 07.06.2012 - 14:00
Location Universität Basel, Organische Chemie

Confirmed Speakers:

  • Neil Pegg, Cellcentric Cambridge, UK, «Epigenetics: Providing new targets for drug discovery»
  • Andre Fischer, University og Goetttingen / Max Planck Institute for Experimental Medicine, Germany, «Epigenetic mechanisms in neurodegenerative diseases»
  • Chun-Wa Chung, Inhibitors of epigenetic bromodomains extend the druggable genome, «Exploiting epigenetic bromodomains: From phenotypic to fragment based drug discovery»
  • Michael G. Schultz, Novartis Institute for Biomedical Research, Cambridge USA, «HDAC Inhibitors: Not for the faint of heart - or are they?»

Contact:

Karl-Heinz Altmann,